BEAMER to attend the 2025 World Evidence, Pricing, and Access Congress
We are excited to announce that BEAMER will be attending the Amsterdam 2025 World Evidence, [...]
Read More
13
Jun
Jun
BEAMER Consortium Teams Up with Privacy Symposium to Spotlight Healthcare Data Privacy in Venice Event
Data has repeatedly been characterised as the “new gold”, highlighting its growing importance in [...]
Read More
06
Jun
Jun
BEAMER Project Assembly in Antwerp: A Productive Endeavor
Led by the project and coordination team, the BEAMER project assembly in Antwerp on March [...]
Read More
19
Mar
Mar
BEAMER Project to Speak at Health Procurement Thematic Innovation Ecosystem Event
We’re excited to announce that the BEAMER Project will be speaking at a Health Procurement [...]
Read More
13
Feb
Feb
Unlocking the Future of Clinical Trials: The Critical Role of Patient Adherence
In an exploration of the critical facet of patient adherence in clinical trials, Aad R. [...]
Read More
05
Feb
Feb
Understanding Human Behavior To Help Improve Patient Adherence
BEAMER is delighted to announce that its project lead Claire Everitt, the Device Design and [...]
Read More
29
Nov
Nov
BEAMER Gains Positive Reception within the Dutch CRO Community
Recently, Sjaak Bloem and I had the privilege of presenting the BEAMER project to the [...]
Read More
29
Nov
Nov
BEAMER Meeting in Thessaloniki Sets Vision for Future Healthcare Solutions
It has become a tradition within BEAMER to gather during the autumn months for a [...]
Read More
02
Nov
Nov
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
